Abstract

Metastatic colonization relies on interactions between disseminated cancer cells and the microenvironment in secondary organs. Here, we show that disseminated breast cancer cells evoke phenotypic changes in lung fibroblasts, forming a supportive metastatic niche. Colonization of the lungs confers an inflammatory phenotype in metastasis-associated fibroblasts. Specifically, IL-1α and IL-1β secreted by breast cancer cells induce CXCL9 and CXCL10 production in lung fibroblasts via NF-κB signaling, fueling the growth of lung metastases. Notably, we find that the chemokine receptor CXCR3, that binds CXCL9/10, is specifically expressed in a small subset of breast cancer cells, which exhibits tumor-initiating ability when co-transplanted with fibroblasts and has high JNK signaling that drives IL-1α/β expression. Importantly, disruption of the intercellular JNK-IL-1-CXCL9/10-CXCR3 axis reduces metastatic colonization in xenograft and syngeneic mouse models. These data mechanistically demonstrate an essential role for the molecular crosstalk between breast cancer cells and their fibroblast niche in the progression of metastasis.

How cancer cells engage the microenvironment to establish metastasis is poorly understood. Here, the authors show that CXCR3-expressing breast cancer cells secrete IL-1 to induce a paracrine crosstalk with fibroblasts in the lung, which involves CXCL9/10 production and results in colonization of the lung.

Details

Title
Metastasis-initiating cells induce and exploit a fibroblast niche to fuel malignant colonization of the lungs
Author
Pein Maren 1   VIAFID ORCID Logo  ; Insua-Rodríguez, Jacob 1 ; Tsunaki, Hongu 2 ; Riedel, Angela 2 ; Meier, Jasmin 2 ; Wiedmann Lena 2 ; Decker, Kristin 1 ; Essers, Marieke A, G 3 ; Sinn Hans-Peter 4   VIAFID ORCID Logo  ; Spaich Saskia 5 ; Sütterlin, Marc 5 ; Schneeweiss, Andreas 6 ; Trumpp, Andreas 7   VIAFID ORCID Logo  ; Oskarsson Thordur 8 

 Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany (GRID:grid.482664.a); Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584); University of Heidelberg, Faculty of Biosciences, Heidelberg, Germany (GRID:grid.7700.0) (ISNI:0000 0001 2190 4373) 
 Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany (GRID:grid.482664.a); Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584) 
 Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany (GRID:grid.482664.a); Division of Inflammatory Stress in Stem Cells, German Cancer Research Center (DKFZ), Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584); DKFZ-ZMBH Alliance, Heidelberg, Germany (GRID:grid.7700.0) (ISNI:0000 0001 2190 4373) 
 University of Heidelberg, Institute of Pathology, Heidelberg, Germany (GRID:grid.7700.0) (ISNI:0000 0001 2190 4373) 
 University Medical Centre Mannheim, Heidelberg University, Department of Obstetrics and Gynaecology, Mannheim, Germany (GRID:grid.411778.c) (ISNI:0000 0001 2162 1728) 
 Heidelberg University Hospital, German Cancer Research Center, National Center for Tumor Diseases, Heidelberg, Germany (GRID:grid.411778.c) 
 Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany (GRID:grid.482664.a); Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584); DKFZ-ZMBH Alliance, Heidelberg, Germany (GRID:grid.7700.0) (ISNI:0000 0001 2190 4373); German Cancer Consortium (DKTK), Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584) 
 Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany (GRID:grid.482664.a); Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584); German Cancer Consortium (DKTK), Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2380032703
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.